Supernus Pharmaceuticals, Inc. (SUPN)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Supernus Pharmaceuticals, Inc. (SUPN) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $2.77B, a trailing price-to-earnings ratio of 21.4 and a free-cash-flow yield of 1.7%. Over the most recent reported fiscal year, revenue grew 8.6% and free cash flow per share fell 73.4%.

Market cap	$2.77B
Trailing P/E	21.4
FCF yield	1.7%
Revenue growth (YoY)	+8.6%
EPS growth (YoY)	+10.9%
FCF/share growth (YoY)	-73.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live SUPN data on Nama Insights →

Recent Congressional trades

Supernus Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 4, 2025
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Dec 14, 2020
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Aug 19, 2020
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 11, 2020
Josh Gottheimer	House	Buy	$1,001 - $15,000	Jun 8, 2020